SLC22A5 and systemic primary carnitine deficiency disease: Downregulation of SLC22A5 can induce primary carnitine deficiency, which is characterized by encephalopathy, cardiomyopathy, cardiomegaly, metabolic derangement, hypoglycemia, and muscle weakness [28,29].